Hospital de la Santa Creu i Sant Pau is a highly complex hospital which dates back six centuries, making it the oldest hospital in Spain. Its activities focus on Barcelona but extend to the rest of Catalonia. The centre plays a prominent role at a Spanish level and is internationally renowned.

We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.

Esade Careers bridges the gap between academia and the professional world, offering personalized career guidance to students. Through innovative tools, dynamic activities, and close collaboration with international companies and Esade Alumni, we foster networking and prepare top talent to meet the challenges of the global job market. #DoGoodDoBetter

Punto Health connects patients, families and providers through an AI-powered platform facilitating continuous and personalised support. From mild cognitive impairment to more advanced dementia stages, we provide a trusted companion along the way.

Som un Servei de diagnòstic biomèdic centrat en el pacient. Integrem totes les diferents àrees de coneixement de la Medicina del Laboratori. Tenim com a objectiu principal generar dades analítiques i integrar-les en informació útil amb valor diagnòstic, pronòstic i de monitoratge terapèutic de les malalties i col·laborar estretament amb els clínics en el procés assistencial del pacient.

L'Institut Català de la Salut vol ressaltar els principals actius de la institució: la plantilla de professionals, l’assistència des de l’embaràs fins a la vellesa, l’abast territorial, un repàs del nombre de centres i el coneixement que promou l’organització a través de formació, la docència, la recerca i la innovació.

At Noah Labs, we empower patients with cardiovascular conditions to live healthier, longer lives by developing voice-based biomarkers for early detection and enabling the most accessible remote monitoring.

Angelini Ventures is the venture capital arm of Angelini Industries funded with a €300 million capital commitment to build and invest in companies that develop innovative ideas and solutions in biotechnology, digital health and life sciences. Angelini Ventures invests across Europe and North America with a focus on brain health and consumer segments such as women, children and the elderly. The company is headquartered in Rome with a global team spread across Europe, Asia and the US to provide global perspective and capabilities.

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - whether in the cardiovascular or oncological field. We know that our success in Europe relies on courageous people who seize opportunities and turn them into results. This is why we encourage our teams across Europe to be passionate about their objectives, challenge conventional thinking and share their local recipes for success and learnings with the whole company. It is only through their input, ideas and honest feedback that we can learn and leverage the full potential of our company. In Europe we are operating in 13 countries. Because of our rather small size compared to larger pharmaceutical companies, each of our employees can have a huge impact – whether they work in the medical area, sales force, business intelligence or the IT department. This is why everybody at Daiichi Sankyo rolls up their sleeves and gets things done, even if this means that they sometimes have to go beyond their usual duties. If you would like to be an active member of our European family, we highly appreciate your application. Please take a look at our current vacancies. Imprint: https://www.daiichi-sankyo.eu/imprint/ All information posted by Daiichi Sankyo Europe on this channel is intended for non-US, non-Canada & non-UK visitors.

LUMO Labs is an impact-driven multi-stage (pre-seed through series A) venture capital fund with coaching program for founding teams. of ventures focused on AI/Data, Blockchain, IoT, VR/AR, and/or Digital Security. We believe these emerging technologies hold the key to solving the social challenges people face today. At LUMO Labs, we focus on sustainable cities and communities, health & Well being, Quality Education, and Climate Action. We create opportunities for people and emerging technologies by connecting impact-driven groundbreaking start-ups to our funds, our expertise, our network and each other. LUMO Labs Eindhoven (the Netherlands) is situated in the heart of the Brainport region where high-tech and design go hand in hand with high-quality manufacturing and entrepreneurship. Collaboration and knowledge-sharing are part of this regions DNA. It is the region where Open Innovation started. Philips Electronics has its origin in the city of Eindhoven. LUMO Labs Los Angeles (United States) is located in Silicon Beach, a booming technology region on the US West Coast. It is home to over 500 tech start-ups, and major technology companies have opened offices in the region. Opposite to Silicon Valley, the L.A. Silicon Beach has a more diversity of industries besides technology. This is in alignment with LUMO Labs multi disciplinary approach.

Withers & Rogers LLP is a leading UK and European firm of patent and trade mark attorneys. Our jurisdiction extends right across Europe as our attorneys represent clients at the European Patent Office, EUIPO - the EU trade mark and design office, and the UK Intellectual Property Office. With over 85 client facing IP professionals spread across six offices, we are able to offer our clients commercially focused intellectual property advice on all aspects of European and international intellectual property law. Our patent, trade mark and registered design attorneys advise on the protection and enforcement of intellectual property rights for inventions, brands, and designs. We have extensive commercial and industrial experience, and our technical expertise spans all major technologies. Withers & Rogers has many long-standing clients both domestic and overseas; we are privileged to represent many prestigious international, brand focused and innovative companies, as well as dynamic SMEs and leading academic institutions. Although based in Europe, we maintain an established worldwide network of contacts including both trusted foreign intellectual property law firms and direct clients. Every year, we invest significant time visiting all major territories to build and maintain these relationships. As such we are able to offer a truly global service in the field of IP to any of our clients.

Arctic Therapeutics is a clinical-stage biopharmaceutical company on a mission to treat and even prevent some of the world’s most pressing diseases by utilizing genetic sequencing to analyze and map the genetic causes of diseases at a granular level, applying our findings to develop effective treatments. Our company was founded by Dr. Hakon Hakonarson in 2015 as a spin-off from the US-based Center for Applied Genomics (CAG), which he launched in 2006 and established it as the largest pediatric biobank and genomic database in the world. We maintain close research relationships with CAG and the Children’s Hospital of Philadelphia. We are committed to developing novel and transformative medicines to create a better future for people in critical need of new treatment options. Our product portfolio is designed to make a significant impact on diseases with high unmet need, ranging from rare and common forms of dementia to inflammatory skin disease and autoimmune disorders Our approach is built on a strong foundation of internal discovery efforts, complemented by collaborations with academic institutions, industry partners, and business development initiatives to expand our pipeline. With patients at the center of everything we do, our goal is to accelerate the development of new treatments and bring them to market faster—delivering real impact for those in need.

At Optum Ventures, we look for exceptional teams with data-driven technologies and services that are poised to deeply disrupt the status quo. By investing in early-stage companies with a transformative vision for making health care better for everyone, we will affect change. We have a goal to connect, accelerate and grow the incredible ideas developed by our portfolio companies with the key health care players that need them most.

L’Hospital Germans Trias és un centre públic, situat en el marc del Campus Can Ruti, que presta atenció sanitària d'alta complexitat a les 800.000 persones que viuen al Barcelonès Nord i al Maresme, així com a alguns ciutadans d'altres territoris catalans en el cas de determinades patologies, en què l'hospital és referència per a fins a 1.200.000 habitants. L'Hospital el gestiona la Gerència Territorial Metropolitana Nord de l'Institut Català de la Salut (ICS), que també és responsable de l'Atenció Primària del Barcelonès Nord, el Maresme, el Vallès Oriental i el Vallès Occidental.

HealthTech Capital is a group of private investors dedicated to funding and mentoring new “HealthTech” start ups at the intersection of healthcare and the computer/consumer electronic world. Our goal is to invest and mentor capital efficient companies that use new scalable business model to improve the efficiency of healthcare delivery from the hospital to the home. HealthTech is now an exploding healthcare market that leverages information technologies to decrease healthcare cost. Historically, venture funding has focused on “Efficacy” (therapeutics drugs and medical devices) and paid little attention to improving “Efficiencies” of healthcare delivery. Today, new paradigm shifting companies like Google, Microsoft, Intel, Apple, Amazon and others are turning their attention to HealthTech. HealthTech supports patient-centric healthcare and is distinct from Healthcare IT, enterprise backbone legacy information systems that are well served by existing major players. Our goal is to invest in capital efficient companies that use new business models to improve the efficiency of healthcare delivery.

Vorwerk Ventures is an independent venture capital fund (in its 4th fund generation) from Germany with assets under management of over €400 million. We are supporting startups that drive meaningful change for people and planet. Our investment focus is on the Consumer, Food, Health, and Climate sectors. Built on decades of expertise and a strong track record, we are guided by a thesis-driven investment strategy. Our highly experienced team combines deep domain knowledge with a hands-on approach to support founders, offering expert guidance and access to a robust network of follow-on investors. At Vorwerk Ventures, we believe visionary entrepreneurs can shape a better future for people and the planet. We are proud to partner with startups making this vision a reality. Headquartered in Berlin, one of Europe’s leading startup hubs, we are constantly on the lookout for opportunities and invest in Seed/Series A with tickets of €1m to €5m and reserve up to €15m for future growth.

Universitatsklinikum Essen is a medical university that offers research and development in addition to medical service and teaching. cardiovascular medicine, immunology, cancer, and transplantation, as well as behavioral sciences, infectious diseases, and translational neuroscience.

With Nui, you'll find all the essential information on caregiving and answers to your individual questions. The app helps you apply for entitled benefits, streamlines daily organization, and optimizes your caregiving budget. And the best part: Behind Nui is a team of caregiving experts ready to assist you personally. #caregiving #familycaregivers #digitalization

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

SH:24 is a fully integrated digital sexual and reproductive health service, delivered in partnership with the UK’s National Health Service. SH:24 makes it easier for people to access STI testing, chlamydia treatment, partner notification, contraception and clinical support - 24 hours a day. Working in partnership with specialist sexual & reproductive health providers and primary care, SH:24 helps to transform and modernise healthcare services. We put people at the heart of what we do. We design services that are easier to use, access and understand. We are passionate about delivering discreet, convenient and clinically safe experiences. Our brands include Fettle.health (https://fettle.health/), which offers users the choice of paying for sexual and reproductive health services online.

Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers. We do this thanks to a commercial model that aligns incentives (fixed-price quotes per study, with milestone-based payments), marrying a world-class clinical operations team with our AI-software platform, and access to 40 million Electronic Health Records. We handle the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management. We have helped over 40 sponsors run entire clinical studies across the US, UK, and Europe up to 72.9% faster than traditional CROs.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Tandem Health is a Federally Qualified Health Center (FQHC) and accredited patient-centered medical home (PCMH) providing comprehensive, personalized healthcare services to the Sumter community at large regardless of their ability to pay. We are not a free clinic. Rather we offer a sliding fee scale to qualifying patients based on the size of their family and income to improve their access to the high quality healthcare services they deserve. We also accept most insurances, including Medicare and Medicaid, enhancing our ability to care for our local community.

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Allianz Partners is a world leader in B2B2C insurance and assistance, offering global solutions that span international health and life, travel insurance, automotive and assistance. Customer driven, our innovative experts are redefining insurance services by delivering future-ready, high-tech high-touch products and solutions that go beyond traditional insurance. Our products are embedded seamlessly into our partners’ businesses or sold directly to customers, and are available through four commercial brands: Allianz Assistance, Allianz Automotive, Allianz Travel and Allianz Care. Present in 75 countries, our 21,100 employees speak 70 languages, handle over 71 million cases each year, and are motivated to go the extra mile to offer peace of mind to our customers around the world. As part of the Allianz Group, we are proud to be the Worldwide Insurance Partner of the Olympic and Paralympic Movements. For more information, please visit: www.allianz-partners.com